Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Henagliflozin/metformin/retagliptin - Shandong Suncadia Medicine

Next Previous
X
Search
Drug Profile

Henagliflozin/metformin/retagliptin - Shandong Suncadia Medicine

Alternative Names: henagliflozin/retagliptin/metformin - Shandong Suncadia Medicine Co; HR-20031; Metformin/henagliflozin/retagliptin - Shandong Suncadia Medicine Co; Retagliptin/metformin/henagliflozin - Shandong Suncadia Medicine Co

Latest Information Update: 04 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shandong Suncadia Medicine
  • Class Antihyperglycaemics; Biguanides; Carboxylic acids; Chlorobenzenes; Ethers; Fluorobenzenes; Glucosides; Imidazoles; Pyrazines; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Type 2 diabetes mellitus

Most Recent Events

  • 04 Dec 2023 Phase-III clinical trials in Type 2 diabetes mellitus (PO), prior to December 2023 (Jiangsu Hengrui Medicine pipeline, December 2023)
  • 04 Apr 2023 Shandong Suncadia Medicine completes a phase I bioequivalence trial in Type 2 diabetes mellitus (In volunteers) in China (NCT05682495)
  • 11 Mar 2023 Shandong Suncadia Medicine completes a phase I trial in Type 2 diabetes mellitus (In adults, In volunteers) in China (PO) (NCT05692934)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top